Please select from the following list of abstracts, representing presentations given at Athens 2002 (IWWM-2) Session 5:
Nucleoside analog therapy in Waldenstrom's Macroglobulinemia (WM). V. Leblond.
2-Chlorodeoxydenosine (2-CdA) Alone or in Combination for Waldesntrom's Macroglobulinemia (WM). DM Weber, MA Dimopoulos, K Delasalle, K Rankin, M Gavino, R Alexanian.
Cladribine (2-CdA) alone or in combination with Mitoxantrone in the treatment of Waldenstrom's macroglobulinemia and first results with Bendamustine plus Rituximab: Results of prospective multicenter studies of a German lymphoma study group. Mathias Rummel and Paris Mitrou.
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's Macroglobulinemia, and mantle-cell lymphoma. JM Foran, AZ Rohatiner, B Coiffier, T Barbui, SA Johnson, W Hiddemann, JA Radford, AJ Norton, SM Tollerfield, MP Wilson, TA Lister.
